Gregory S. Curhan - 15 Dec 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role: Interim Chief Financial Officer
Signature: /s/ Jennifer J. Rhodes, as attorney-in fact for Gregory S. Curhan
Issuer symbol: ELTX
Transactions as of: 15 Dec 2021
Net transactions value: +$9,480
Form type: 4
Filing time: 16 Dec 2021, 15:58:02 UTC
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELTX	Common Stock	Purchase	$9,480	+4,000		$2.37	4,000	15 Dec 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Interim Chief Financial Officer